Skip to content
AI and pharma R&D: A guide to getting to market faster 
Between 2021 and 2022, the cost to develop a new drug soared by 12.5% from $1.96 billion to $2.24 billion, underscoring the urgent need for innovations like AI to streamline R&D processes, curb expenses, and speed up market entry.

This guide explores how R&D teams in pharma organizations can use AI to streamline drug discovery, accelerate clinical trials and eliminate duplication of efforts.

Download your copy to learn how innovative pharma leaders are using AI to:

  • Streamline drug discovery by quickly identifying promising drug targets and expediting early-stage research.
  • Accelerate clinical trials by designing more efficient trial protocols, optimizing patient recruitment and navigating regulatory requirements with ease.
  • Eliminate duplication of efforts by connecting researchers with relevant expertise and past research findings, avoiding redundant work and fostering collaboration across teams.
 
[STRM] Guide_AI and pharma R&D_Promo Image A (1)

 

Download Now

Lets connect.

If you’re looking to reduce sales cycle and speed up conversion through instant access to expert knowledge, people and best practices, you’ve come to the right place.

Get in touch